Merck KGaA (MRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Merck KGaA (MRK) has a cash flow conversion efficiency ratio of 0.020x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€605.00 Million ≈ $707.31 Million USD) by net assets (€30.29 Billion ≈ $35.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Merck KGaA for the company's overall valuation and market capitalisation.
Merck KGaA - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Merck KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Merck KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Merck KGaA ranked by their cash flow conversion efficiency. Explore how high is Merck KGaA's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tower Semiconductor Ltd
TA:TSEM
|
0.058x |
|
Arca Continental S.A.B. de C.V
MX:AC
|
0.051x |
|
Evolution Mining Ltd
AU:EVN
|
0.222x |
|
Grace Fabric Technology Co Ltd
SHG:603256
|
0.028x |
|
Krung Thai Bank Public Company Limited
BK:KTB
|
0.286x |
|
Fubon Financial Holding Co Ltd Pref B
TW:2881B
|
0.005x |
|
Huatai Securities Co Ltd
SHG:601688
|
0.170x |
|
Helvetia Holding AG
SW:HELN
|
0.064x |
Annual Cash Flow Conversion Efficiency for Merck KGaA (2002–2025)
The table below shows the annual cash flow conversion efficiency of Merck KGaA from 2002 to 2025. View current stock price of Merck KGaA for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €28.66 Billion ≈ $33.51 Billion |
€3.93 Billion ≈ $4.60 Billion |
0.137x | -10.29% |
| 2024-12-31 | €29.99 Billion ≈ $35.06 Billion |
€4.59 Billion ≈ $5.36 Billion |
0.153x | +8.13% |
| 2023-12-31 | €26.75 Billion ≈ $31.28 Billion |
€3.78 Billion ≈ $4.42 Billion |
0.141x | -13.64% |
| 2022-12-31 | €26.00 Billion ≈ $30.40 Billion |
€4.26 Billion ≈ $4.98 Billion |
0.164x | -24.02% |
| 2021-12-31 | €21.42 Billion ≈ $25.04 Billion |
€4.62 Billion ≈ $5.40 Billion |
0.216x | +5.49% |
| 2020-12-31 | €17.02 Billion ≈ $19.89 Billion |
€3.48 Billion ≈ $4.06 Billion |
0.204x | +28.15% |
| 2019-12-31 | €17.91 Billion ≈ $20.94 Billion |
€2.86 Billion ≈ $3.34 Billion |
0.159x | +23.82% |
| 2018-12-31 | €17.23 Billion ≈ $20.15 Billion |
€2.22 Billion ≈ $2.59 Billion |
0.129x | -32.82% |
| 2017-12-31 | €14.07 Billion ≈ $16.44 Billion |
€2.70 Billion ≈ $3.15 Billion |
0.192x | +6.95% |
| 2016-12-31 | €14.05 Billion ≈ $16.43 Billion |
€2.52 Billion ≈ $2.94 Billion |
0.179x | +4.95% |
| 2015-12-31 | €12.86 Billion ≈ $15.03 Billion |
€2.20 Billion ≈ $2.57 Billion |
0.171x | -25.52% |
| 2014-12-31 | €11.80 Billion ≈ $13.80 Billion |
€2.71 Billion ≈ $3.16 Billion |
0.229x | +14.03% |
| 2013-12-31 | €11.07 Billion ≈ $12.94 Billion |
€2.23 Billion ≈ $2.60 Billion |
0.201x | -15.30% |
| 2012-12-31 | €10.41 Billion ≈ $12.18 Billion |
€2.47 Billion ≈ $2.89 Billion |
0.237x | +95.95% |
| 2011-12-31 | €10.49 Billion ≈ $12.27 Billion |
€1.27 Billion ≈ $1.49 Billion |
0.121x | -29.51% |
| 2010-12-31 | €10.37 Billion ≈ $12.13 Billion |
€1.78 Billion ≈ $2.08 Billion |
0.172x | +19.24% |
| 2009-12-31 | €9.51 Billion ≈ $11.12 Billion |
€1.37 Billion ≈ $1.60 Billion |
0.144x | +35.42% |
| 2008-12-31 | €9.62 Billion ≈ $11.25 Billion |
€1.02 Billion ≈ $1.20 Billion |
0.106x | -24.10% |
| 2007-12-31 | €8.69 Billion ≈ $10.16 Billion |
€1.22 Billion ≈ $1.42 Billion |
0.140x | -34.22% |
| 2006-12-31 | €3.81 Billion ≈ $4.45 Billion |
€811.70 Million ≈ $948.96 Million |
0.213x | -3.11% |
| 2005-12-31 | €3.33 Billion ≈ $3.89 Billion |
€732.50 Million ≈ $856.37 Million |
0.220x | +11.57% |
| 2004-12-31 | €2.89 Billion ≈ $3.38 Billion |
€570.90 Million ≈ $667.44 Million |
0.197x | -38.07% |
| 2003-12-31 | €2.36 Billion ≈ $2.76 Billion |
€752.40 Million ≈ $879.63 Million |
0.318x | +55.07% |
| 2002-12-31 | €2.05 Billion ≈ $2.40 Billion |
€421.70 Million ≈ $493.01 Million |
0.205x | -- |
About Merck KGaA
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for re… Read more